Author

Parvaneh Rahimi‐Moghaddam

Observed names: P Rahimi-Moghaddam, P. RAHIMI-MOGHADDAM, P. Rahimi-Moghaddam, Parvaneh Rahimi-Moghaddam, Parvaneh RAHIMI‐MOGHADDAM, Parvaneh Rahimi Moghaddam, Parvaneh Rahimi-Moghadam, Parvaneh Rahimi-Moghaddam, Parvaneh Rahimi-moghaddam, Rahimi-Moghaddam, Parvaneh
ORCID: 0000-0001-9344-8143
Observed ORCID: 0000-0001-9344-8143
OpenAlex ID: A5083197578
2008 · Massoud Mahmoudian, Parvaneh Rahimi-Moghaddam · Recent Patents on Anti-Cancer Drug Discovery · 150
2011 · Parvaneh Rahimi-Moghaddam, Soltan Ahmed Ebrahimi, et al. · PubMed Central · 38
2007 · Nastaran Heidari, Bahram Goliaei, et al. · Anti-Cancer Drugs · 36
2012 · Zahra Kiani, Massoumeh Shafiei, et al. · Analytica Chimica Acta · 35
2009 · F. Benaissa, H. Mohseni-Rad, et al. · Acta Physiologica Hungarica · 22
2006 · N. IZADI MOOD, Z. EFTEKHAR, et al. · International Journal of Gynecological Cancer · 20
2009 · Narges Izadi Mood, Nasrin Samadi, et al. · PubMed Central · 19
2007 · Farideh Sepahvand, Massoumeh Shafiei, et al. · Basic & Clinical Pharmacology & Toxicology · 19
2007 · Farideh Sepahvand, Parvaneh Rahimi-Moghaddam, et al. · Journal of Toxicology and Environmental Health · 19
2024 · Afrooz Mohammadgholi-Beiki, Mohammad Sheibani, et al. · International Immunopharmacology · 18
2009 · Bahareh Tavakoli-Far, Nahid Rahbar-Roshandel, et al. · European Journal of Pharmacology · 16
2023 · Valentina A. Babenko, Ksenia S. Fedulova, et al. · Journal of Personalized Medicine · 15
2020 · Foad Ghazizadeh, Massoumeh Shafiei, et al. · Evidence-based Complementary and Alternative Medicine · 13
1996 · Aryamanesh, Simin, Seyyed Meisam Ebrahimi, et al. · Europe PMC (PubMed Central) · 13
2011 · Fatemeh Namvaran, Parvaneh Rahimi-Moghaddam, et al. · PubMed Central · 11
2024 · Helia Aghamiri, Afrooz Mohammadgholi-Beiki, et al. · Inflammopharmacology · 9
2020 · Elham Ghorbani, Mahsa Mohammadi, et al. · Biochemical Genetics · 7
Works count: 55
Citation count: 2,048
H-index: 16
I10-index: 22
Year
Topic
Type